Does LORLATINIB Cause Peripheral swelling? 164 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 164 reports of Peripheral swelling have been filed in association with LORLATINIB (Lorbrena). This represents 3.0% of all adverse event reports for LORLATINIB.
164
Reports of Peripheral swelling with LORLATINIB
3.0%
of all LORLATINIB reports
21
Deaths
30
Hospitalizations
How Dangerous Is Peripheral swelling From LORLATINIB?
Of the 164 reports, 21 (12.8%) resulted in death, 30 (18.3%) required hospitalization.
Is Peripheral swelling Listed in the Official Label?
Yes, Peripheral swelling is listed as a known adverse reaction in the official FDA drug label for LORLATINIB.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which LORLATINIB Alternatives Have Lower Peripheral swelling Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE